Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - amisulpride 200 mg - comprimé - 200 mg - amisulpride 200 mg - amisulpride

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

sanofi winthrop industrie - amisulpride 200 mg - comprimé - 200 mg - pour un comprimé > amisulpride 200 mg - antipsychotique code atc : n05al05 - classe pharmacothérapeutique : antipsychotique - code atc : n05al05solian appartient à une famille de médicaments appelés antipsychotiques.ce médicament est utilisé pour traiter les personnes souffrant de schizophrénie. la schizophrénie est une maladie mentale caractérisée par certains troubles psychiques et du comportement, comme par exemple des hallucinations ou de l’agitation.

Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - amisulpride 200 mg - tablet - 200 mg - amisulpride 200 mg - amisulpride

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amisulpride, quantity: 200 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; methylcellulose; lactose monohydrate; sodium starch glycollate type a - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amisulpride, quantity: 100 mg - tablet - excipient ingredients: sodium starch glycollate type a; lactose monohydrate; microcrystalline cellulose; methylcellulose; magnesium stearate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amisulpride, quantity: 50 mg - tablet - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; methylcellulose; magnesium stearate; microcrystalline cellulose - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amisulpride, quantity: 400 mg - tablet, film coated - excipient ingredients: macrogol 6000; methylcellulose; purified talc; magnesium stearate; sodium starch glycollate type a; microcrystalline cellulose; basic butylated methacrylate copolymer; titanium dioxide; lactose monohydrate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

rivopharm (uk) ltd - amisulpride - oral tablet - 200mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - amisulpride - oral tablet - 200mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - amisulpride - oral tablet - 200mg